Dark

Check out our Level2View

REPH
Recro Pharma, Inc.
stock NASDAQ

Inactive

Mar 21, 2022

2.05USD-2.381%(-0.05)141,803

Pre-market

0.00USD-100.000%(-2.10)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 26, 2022

07:00AM EST Recro Wins $1.5 Million Formulation Development and CGMP GlobeNewswire Inc

Jan 19, 2022

07:00AM EST Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego GlobeNewswire Inc

Jan 6, 2022

04:05PM EST Recro Pharma, Inc. (Recro; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles in technical operations. GlobeNewswire Inc

Jan 3, 2022

07:00AM EST Recro to Present at H.C. Wainwright BioConnect 2022 Conference GlobeNewswire Inc

Dec 2, 2021

07:00AM EST Recro to Present at Stephens Annual Investment Conference GlobeNewswire Inc

Nov 9, 2021

06:11PM EST Recro Pharma Q3 EPS $(0.07), Inline, Sales $18.24M Beat $18.07M Estimate Benzinga

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 8, 2021

10:01AM EST Recro Pharma Earnings Preview Benzinga

Oct 27, 2021

07:00AM EDT Recro Enters Into Master Commercial Supply and Services Agreement GlobeNewswire Inc

Oct 20, 2021

07:12AM EDT Recro Awarded $1.87M Development And Manufacturing Contract By National Institutes Of Health To Support Novel Nasal Spray Analgesic Benzinga

07:00AM EDT Recro Awarded Development and Manufacturing Contract by National GlobeNewswire Inc

Oct 12, 2021

10:48AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 Benzinga

07:17AM EDT William Blair Initiates Coverage On Recro Pharma with Outperform Rating Benzinga

Oct 6, 2021

07:00AM EDT Recro Reports Inducement Grants For New Staff GlobeNewswire Inc

Sep 21, 2021

07:06AM EDT Recro Signs Renewable Energy Agreement With Georgia Power Benzinga

Sep 16, 2021

11:36AM EDT Recro Pharma's Return On Capital Employed Overview Benzinga

Sep 8, 2021

07:00AM EDT Recro and BioCorRx Expand Development and Manufacturing GlobeNewswire Inc

Aug 17, 2021

07:00AM EDT Acquisition Expands Recros Global Customer Base and Service Offerings, Creates Bi-Coastal CDMO, Diversifies Pipeline and Revenue Sources, and Provides Additional Pathway for Continued Growth GlobeNewswire Inc

Aug 13, 2021

08:51AM EDT Recro Acquires IRISYS For ~$50M Benzinga

08:50AM EDT Combination of Synergistic Organizations Results in Broad CDMO Service with Capabilities Spanning from Pre-IND Development to Commercial Manufacturing and Packaging for Wide Range of Dosage Forms GlobeNewswire Inc

Aug 10, 2021

01:02PM EDT Recro To Acquire Undisclosed Full-Service CDMO For Around $50M, Q2 Earnings Top Estimates Benzinga

07:04AM EDT Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO; Recro Agreed To Acquire 100% Of The Equity Interests Of The Target In Exchange For Consideration Having An Aggregate Value Of ~$49.85M Benzinga

07:00AM EDT Recro Announces Entry Into Letter of Intent for Acquisition of a GlobeNewswire Inc

Aug 9, 2021

05:06PM EDT Recro Pharma: Q2 Earnings Insights Benzinga

04:57PM EDT Recro Pharma Q2 EPS $0.03 Beats $(0.11) Estimate, Sales $18.02M Beat $17.10M Estimate Benzinga

04:05PM EDT Q2 2021 Highlighted by Revenues of $18.0 Million, an Increase of 16% Compared to Q2 2020 Revenue GlobeNewswire Inc

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Aug 8, 2021

10:11AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 2, 2021

04:05PM EDT Recro To Report Financial Results for Second Quarter 2021 on GlobeNewswire Inc

02:17PM EDT Cowen Prime Advisors Reports In 13G Filing A 6% Stake In Recro Pharma Benzinga

Jul 20, 2021

07:40AM EDT Recro Pharma Appoints Erica Raether As Vice President Of People, Culture And ESG RTTNews

07:00AM EDT Recro Appoints Erica Raether as Vice President of People, Culture GlobeNewswire Inc

Jul 13, 2021

07:01AM EDT Recro Enters Development and Manufacturing Agreement With New Client GlobeNewswire Inc

Jul 7, 2021

07:00AM EDT Recro Reports Inducement Grants for New Staff GlobeNewswire Inc

Jun 16, 2021

07:12AM EDT Recro Pharma Appoints Laura Parks To Board RTTNews

07:00AM EDT Recro Appoints Laura L. Parks, Ph.D. to Board of Directors GlobeNewswire Inc

Jun 2, 2021

07:01AM EDT Recro Expands Capabilities for Growing Clinical Trial Services Offerings Benzinga

07:00AM EDT Recro Expands Capabilities for Growing Clinical Trial Services GlobeNewswire Inc

May 18, 2021

07:08AM EDT Recro Enters Development Agreement With Astex Pharmaceuticals; Financial Details Not Disclosed Benzinga

07:05AM EDT Recro Pharma Inks New Development Agreement With Astex Pharma RTTNews

07:00AM EDT Recro Pharma, Inc. (Recro; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the signing of a new development agreement with Astex Pharmaceuticals, Inc. GlobeNewswire Inc

May 14, 2021

09:15AM EDT Underwriters Full Exercise of Option Brings Gross Proceeds to $34.5 Million GlobeNewswire Inc

May 12, 2021

08:46AM EDT Recro Pharma Prices Public Offering Of 13.33 Mln Shares At $2.25 Per Share RTTNews

08:32AM EDT Recro Pharma Prices 13.33M Share Common Stock Offering At $2.25 Per Share Benzinga

08:31AM EDT Recro Announces Pricing of $30.0 Million Public Offering of Common GlobeNewswire Inc

May 11, 2021

04:49PM EDT Recro Announces Proposed Public Offering Of Common Stock; Size Not Disclosed Benzinga

04:30PM EDT Recro Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

May 6, 2021

05:14PM EDT Recro Pharma Sees FY21 Sales $68M-$72M vs. $70.96M Est. Benzinga

05:14PM EDT Recro Pharma Q1 EPS $(0.23) Beats $(0.25) Estimate, Sales $16.80M Beat $16.43M Estimate Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 5, 2021

10:07AM EDT Earnings Preview for Recro Pharma Benzinga

Apr 15, 2021

07:09AM EDT Recro Pharma Signs Additional Agreements With An Existing Customer, Ensysce Biosciences RTTNews

07:00AM EDT Recro Expands Development and Manufacturing Relationship With GlobeNewswire Inc

Apr 6, 2021

07:00AM EDT Recro Reports Inducement Grants for New Staff GlobeNewswire Inc

Apr 5, 2021

07:00AM EDT Six Recent Hires Provide Broader Coverage and Expanded Capabilities in the Areas of Sales and Marketing GlobeNewswire Inc

Mar 2, 2021

07:00AM EST Recro to Present at H.C. Wainwright Global Life Science Conference GlobeNewswire Inc

Feb 26, 2021

02:50PM EST Mid-Afternoon Market Update: Crude Oil Down Over 3%; AMC Networks Shares Surge After Q4 Results Benzinga

12:17PM EST Mid-Day Market Update: Nasdaq Rises Over 100 Points; Recro Pharma Shares Plummet Benzinga

10:21AM EST Mid-Morning Market Update: Markets Mostly Lower; Foot Locker Reports Mixed Q4 Results Benzinga

08:17AM EST The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida Benzinga

07:18AM EST Recro Pharma Q4 EPS $(0.48) Misses $(0.25) Estimate, Sales $9.91M Miss $15.00M Estimate Benzinga

07:00AM EST Recro Reports Fourth Quarter and Year End 2020 Financial Results GlobeNewswire Inc

04:52AM EST Earnings Scheduled For February 26, 2021 Benzinga

Feb 25, 2021

10:03AM EST Earnings Preview for Recro Pharma Benzinga

Feb 23, 2021

04:05PM EST Recro to Report Fourth Quarter and Year-End 2020 Financial Results GlobeNewswire Inc

07:13AM EST Recro Pharma Shares Down 7%; Co Announces Amendment To Athyrium Credit Facility Benzinga

07:00AM EST Recro Announces Amendment to Athyrium Credit Facility GlobeNewswire Inc

Feb 19, 2021

04:05PM EST Recro to Report Financial Results for Fourth Quarter And Year-End GlobeNewswire Inc

Feb 11, 2021

07:00AM EST Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial Officer GlobeNewswire Inc

Dec 18, 2020

09:34PM EST Recro Grants Inducement Award to New Chief Executive Officer GlobeNewswire Inc

Dec 16, 2020

07:10AM EST Recro Names David Enloe President, CEO And Member Of Board RTTNews

07:06AM EST Recro Announces David Enloe Has Been Named President, CEO and Member of Board Benzinga

07:01AM EST Recro Announces Executive Changes GlobeNewswire Inc

Nov 9, 2020

07:25AM EST Recap: Recro Pharma Q3 Earnings Benzinga

07:20AM EST Recro Pharma Q3 EPS $(0.09) Beats $(0.20) Estimate, Sales $19.29M Beat $16.33M Estimate Benzinga

07:00AM EST Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM, Verelan SR and Verapamil PM GlobeNewswire Inc

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Nov 2, 2020

07:00AM EST Recro to Report Third Quarter 2020 Financial Results and Host GlobeNewswire Inc

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Oct 29, 2020

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 27, 2020

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

Sep 18, 2020

07:30AM EDT Recro to Present at Oppenheimer Fall Healthcare Life Sciences & GlobeNewswire Inc

Aug 14, 2020

08:26AM EDT The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal Benzinga

Aug 13, 2020

08:18AM EDT The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga

Aug 10, 2020

10:53AM EDT Shares of Recro Pharma, Inc. (REPH) are down nearly 30% on Monday morning after the company's second-quarter results miss street estimates. RTTNews

07:49AM EDT Recro Pharma Q2 EPS $(0.25) Misses $(0.16) Estimate, Sales $15.52M Miss $18.88M Estimate Benzinga

07:22AM EDT Recro Pharma: Q2 Earnings Insights Benzinga

07:00AM EDT Launches Clinical Trial Materials Business and Secures New Customers GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Aug 6, 2020

07:00AM EDT Recro to Report Second Quarter 2020 Financial Results and Host GlobeNewswire Inc

Share